A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Doses of Inhaled CHF10073 in Participants With Idiopathic Pulmonary Fibrosis

​ Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Drug: CHF10073 low dose; Drug: CHF10073 high dose; Drug: Placebo

Sponsors: Chiesi Farmaceutici S.p.A.

Not yet recruiting Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Drug: CHF10073 low dose; Drug: CHF10073 high dose; Drug: Placebo
Sponsors: Chiesi Farmaceutici S.p.A.
Not yet recruiting